Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
136 participants
INTERVENTIONAL
2008-01-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention
NCT00610870
Statin Therapy In Patients With Vasospastic Angina
NCT02790528
Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome
NCT00728988
Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting
NCT02565615
The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm
NCT01674686
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Impaired FMD(flow mediated endothelium-dependent vasodilation) in the brachial artery was demonstrated in vasospastic angina,and improvement of endothelial dysfunction with treatment of statin is documented in several studies.
So, we expect that statin treatment for vasospastic angina provide additional therapeutic effects via improvement of endothelial dysfunction.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Atorvastatin group
atorvastatin
atorvastatin 40mg qd for 1 year
B
Control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
atorvastatin
atorvastatin 40mg qd for 1 year
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal or insignificant lesion (diameter stenosis \<50%) on coronary angiography
Exclusion Criteria
* Significant lesion( diameter stenosis ≥50%) documented in coronary angiography
* Pregnancy
* Prior percutaneous coronary intervention or coronary artery bypass surgery
* Previous statin use
* Impaired renal function with serum creatinine ≥ 2.0 mg/dl
* Severe left ventricular dysfunction ( LVEF ≤ 30% on echocardiography)
* Myopathy
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Samsung Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samsung Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hyun-chul Gwon, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Samsung Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Samsung Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-01-018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.